New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

THURSDAY, Sept. 18, 2025 (HealthDay News) — Aspirin can cut by more than half the risk that colon cancer will come back ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...